Stemtech Corporation
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $299.7K
- Price
- $0.0001
- % Change (Daily % change from the live per-ticker quote feed.)
- 0.00%
- Volume
- 1.1M
About
Stemtech Corporation is a pioneering company specializing in stem cell nutrition. It formulates scientifically-backed products designed to optimize the body's intrinsic stem cell physiology. With a market presence spanning the Americas, Latin America, and Asia, its offerings are engineered to bolster the natural functions of the body's stem cells. These solutions achieve this by stimulating the release of more stem cells, facilitating their efficient circulation through the bloodstream, and guiding their migration into various tissues. This process enables the stem cells to perform their continuous regenerative and repair tasks, crucial for maintaining optimal health and vitality. The company's comprehensive portfolio of dietary supplements includes prominent brands such as RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze. Stemtech Corporation's operations are headquartered in Miramar, Florida.
Quick stats
Quick-stats data pending — refreshes nightly.
Key info
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001511820
Websitehttps://www.stemtech.com
AI Summary
AI-generated1/5
minorbullishoperations update
Physician Cites Stemtech as "Cornerstone" Behind His Focus on STEM Cell Medicine
Stemtech Corporation issued a promotional release citing Pakistan-based physician Dr. Zahoorudin, who credits Stemtech's stem cell nutrition science as the 'cornerstone' of his stem cell medicine practice.
The physician says he is working to expand availability of Stemtech's stemceutical products in Pakistan, which management framed as medical-doctor validation of its science.
The release contains no financial figures, contracts, or measurable business impact; it is a micro-cap brand-awareness piece rather than a material business event.
Red flags
- Promotional testimonial-style release with no quantifiable business impact
- OTC Pink micro-cap with physician-endorsement marketing; no revenue or clinical trial data disclosed